Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Phase II Investigation of Thalidomide for the Treatment of Primary Sclerosing Cholangitis

NCT00953615 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00953615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00953615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Phase II Investigation of Thalidomide for the Treatment of Primary Sclerosing Cholangitis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2006
Completion date
May 31, 2009
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis